Marita Ziepert Selected Research

Monoclonal Gammopathy of Undetermined Significance

3/2011	Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
3/2011	Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marita Ziepert Research Topics

Disease

22	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 02/2008
15	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2021 - 02/2008
14	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 02/2008
10	Lymphoma (Lymphomas) 01/2023 - 09/2008
8	Neoplasms (Cancer) 02/2022 - 09/2008
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 11/2010
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 11/2010
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 11/2010
2	Cardiotoxicity 01/2015 - 01/2014
2	Monoclonal Gammopathy of Undetermined Significance 03/2011 - 03/2011
2	Multiple Myeloma 03/2011 - 03/2011
1	Infections 12/2022
1	Neutropenia 04/2021
1	Disease Progression 01/2021
1	Coinfection 12/2016
1	Colorectal Neoplasms (Colorectal Cancer) 10/2014
1	Breast Neoplasms (Breast Cancer) 10/2014
1	Vitamin D Deficiency 10/2014
1	Pathologic Complete Response 07/2014
1	Central Nervous System Diseases (CNS Diseases) 07/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2011
1	Hematologic Neoplasms (Hematological Malignancy) 03/2011
1	Carcinogenesis 03/2010
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2008

Drug/Important Bio-Agent (IBA)

19	Rituximab (Mabthera)FDA Link 07/2023 - 02/2008
17	Vincristine (Oncovin)FDA LinkGeneric 10/2023 - 02/2008
15	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 02/2008
15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023 - 02/2008
13	Prednisone (Sone)FDA LinkGeneric 01/2023 - 09/2008
8	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2011
3	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 02/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	AnthracyclinesIBA 12/2022 - 01/2015
2	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2008
2	ParaffinIBA 08/2017 - 03/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2015 - 03/2010
2	AntibodiesIBA 10/2014 - 03/2011
2	EnzymesIBA 03/2011 - 03/2010
2	ParaproteinsIBA 03/2011 - 03/2011
1	Vindesine (Vindesin)IBA 01/2023
1	Bendamustine Hydrochloride FDA Link 12/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Fluorine-18IBA 10/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	PlatinumIBA 01/2021
1	Serum AlbuminIBA 07/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	ExotoxinsIBA 12/2018
1	AutoantigensIBA 12/2018
1	EpitopesIBA 12/2018
1	neurabinIBA 12/2018
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 08/2017
1	carboxyl radical (COO-)IBA 08/2017
1	Formaldehyde (Formol)FDA Link 08/2017
1	Immediate-Early ProteinsIBA 12/2016
1	hydroxide ionIBA 10/2014
1	Calcifediol (Calcidiol)FDA Link 10/2014
1	Trastuzumab (Herceptin)FDA Link 10/2014
1	Vitamin D FDA LinkGeneric 10/2014
1	Cetuximab (Erbitux)FDA Link 10/2014
1	Methotrexate (Mexate)FDA LinkGeneric 07/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2014
1	4-demethoxyanthracyclineIBA 01/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2012
1	CytokinesIBA 07/2012
1	Immunoglobulin G (IgG)IBA 03/2011
1	Immunoglobulin M (IgM)IBA 03/2011
1	Immunoglobulin A (IgA)IBA 03/2011
1	Phosphotransferases (Kinase)IBA 11/2010
1	HLA-DR Antigens (HLA-DR)IBA 11/2009
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2008

Therapy/Procedure

9	Therapeutics 03/2024 - 09/2008
7	Radiotherapy 03/2024 - 11/2013
7	Drug Therapy (Chemotherapy) 02/2022 - 09/2008
4	Stem Cell Transplantation 01/2023 - 06/2016
1	Drug Tapering 10/2023
1	Transplantation 12/2012